Richard T. Meehan

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin, Michael D. Roth, Philip J. Clements et al. · The Lancet Respiratory Medicine · 2016 · 1.1K citations

Medicine, Pharmacology, Pharmacotherapy +11

Toll-like receptor 7 (TLR7)–driven accumulation of a novel CD11c+ B-cell population is important for the development of autoimmunity

Anatoly V. Rubtsov, Kira Rubtsova, Aryeh Fischer et al. · Blood · 2011 · 807 citations · Full text

Life Sciences, Immunology, Pathology +13

Mycophenolate Mofetil Improves Lung Function in Connective Tissue Disease-associated Interstitial Lung Disease

Aryeh Fischer, Kevin K. Brown, Roland M. du Bois et al. · The Journal of Rheumatology · 2013 · 395 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

Rheumatoid Arthritis–related Lung Diseases: CT Findings

Nobuyuki Tanaka, Jeung Sook Kim, John D. Newell et al. · Radiology · 2004 · 350 citations

Medicine, Pathology, Radiology +17

Mycophenolate Mofetil Is Safe, Well Tolerated, and Preserves Lung Function in Patients With Connective Tissue Disease-Related Interstitial Lung Disease

Jeffrey J. Swigris, Amy L. Olson, Aryeh Fischer et al. · CHEST Journal · 2006 · 180 citations

Medicine, Pharmacology, Pharmacotherapy +10